Personal profile

Currently, Dr XU Ming is a research professor and Ph.D. supervisor, Dean of the Department of Global Health of the School of Public Health and Associate Dean of the Institute for Global Health and Development of Peking University. He has rich work experience in international development cooperation, and the development of the healthcare industry. He was the Head of the Department for Emerging Economies and previously the Senior Political Advisor for External Relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria in Switzerland. Prior to that, he was the Vice President of China Chamber of Commerce for the Import and Export of Medicines and Health Products under the Ministry of Commerce of China. Earlier, he served in the United Nations Iraq-Kuwait Observation Mission and the Chinese Embassy in the Republic of Korea. When working with the Global Fund, his focus was mainly on the prevention and control of major infectious diseases and health system strengthening in the implementing countries, and building up collaborations with emerging economies in the health field. When working in China, he participated a lot in formulating the policies and regulations of China’s healthcare industry, ranging from the promotion of trade and investment, regulation of medicinal products, to the enhancement of the international competitiveness of companies. He was the chair and PI of key health projects, and the head or member of evaluation groups to review major health projects at the national level. He currently serves as a member of the Technical Advisory Panel (TAP)of the Pandemic Fund and the World Health Organization’s Technical Advisory Group on Local Production and Technology Transfer of Health Products(TAG-LPTT) . He has served as vice president, director and executive member of several academic associations, including China Health Economics Association, the Chinese Preventive Medicine Association, and China Association of Medical Equipment.

He got a Ph.D. in industrial economics from Fudan University and completed his post-doctoral fellowship at Guanghua School of Management of Peking University. He has written more than one hundred papers and articles in journals and specialized publications.

Main research areas

International development cooperation and global public goods for health;

International financing for health;

Cross-border prevention and control of infectious diseases; Internationalization of China’s health care industry

Representative scientific research projects

1. Promotion of China ASEAN science and technology cooperation in public health, Ministry of Science and Technology of China, 2023-2027.

2. Research on challenges to the global Health governance and China’s role, the National Social Science Fund of China, 2023-2026.

3. Development plan of China-ASEAN University Consortium on Medicine and Health (phase Ⅱ), Ministry of Education of China,2024-2025.

4. Accelerating malaria control and elimination in Myanmar by optimizing use of resources, the Gates Foundation, 2022-2025.

5. Debt-to-health swaps in the Chinese international development programs, the Gates Foundation, 2023-2025.

6. Global Health Leadership Development Program, China Medical Board, 2022-2025.

7. Innovative health financing mechanisms and instruments of international organizations, the National Health Commission of China, 2023.

8. Industrial security surveillance platform for the health industry, Ministry of Commerce of China, 2009-2017.

9. The 12^th Five-Year Plan for the Import and Export of China’s Health Industry, Ministry of Commerce of China, 2010.

Recent representative publications

1.Ming Xu*, Christoph Benn, Simon Reid- Henry, Tim Brown, Shuduo Zhou, Jian Yang, Ying Chen, Zhebin Wang. Rethinking International financing for health to better respond to future pandemics. BMJ Global Health, 12 November 2023. https://gh.bmj.com/content/8/11/e012988

2. Yunxuan Hu, Zhebin Wang, Shuduo Zhou, Jian Yang, Ying Chen, Yumeng Wang, Ming Xu*. Redefning Debt-to-Health, a triple-win health financing instrument in global health. Globalization and Health, 6 May 2024. https://doi.org/10.1186/s12992-024-01043-x

3. Shuduo Zhou, Xiangning Feng, Yunxuan Hu, Jian Yang, Ying Chen, Jon Bastow，Zhi‑Jie Zheng，Ming Xu*.Factors associated with the utilization of diagnostic tools among countries with different income levels during the COVID-19 pandemic. Global Health Research and Policy, 27 October 2023. https://doi.org/10.1186/s41256-023-00330-1

4. Yanan Luo, Richard Liang, Ming Xu*. Economic insecurity exposure and cognitive function in late life. Journal of Epidemiology and Community Health; September 2023. https://jech.bmj.com/content/early/2023/09/01/jech-2023-220481

5.Jian Yang, Shuduo Zhou, Xiangning Feng, Ying Chen, Yunxuan Hu, Ming Xu*. Evolving market-shaping strategies to boost access to essential medical products in developing countries with HIV self-testing as a case study. Global Health Research and Policy, 14 July 2023. https://doi.org/10.1186/s41256-023-00310-5

6.Jian Yang, Shuduo Zhou, Xiangning Feng,Ying Chen, Yunxuan Hu, Ming Xu*. Understanding the Effects of Iatrogenic Management on Population Health: A Medical Innovation Perspective. China CDC Weekly 2023; ISSN 2096-3101, CN 10-1629/R1,Vol. 5 No. 27, 7 July 2023.

7.Ming Xu*, Yunxuan Hu, Shenning Lu, Muhammad Abdullahi Idris, Shuduo Zhou, Jian Yang, Xiangning Feng, Yangmu Huang, Xian Xu, Ying Chen, Duoquan Wang. Seasonal malaria chemoprevention in Africa and China's upgraded role as a contributor: scoping review. Infectious Diseases of Poverty, July 2023. https://doi.org/10.1186/s40249-023-01115-x

8. Ming Xu*, Li Zhang, Xiangning Feng, Zhenyu Zhang,Yangmu Huang. Regulatory Reliance for Convergence and Harmonization in the Medical Device Space in Asia-Pacific. BMJ Global Health, 19 August 2022, Volume 7 -Issue 8. https://gh.bmj.com/content/7/8/e009798

9. Siwei Xie, Sijin Du, Yuxin Huang, Yan Luo, Ying Chen, Zhijie Zheng, Beibei Yuan, Ming Xu*, Shuduo Zhou. Evolution and effectiveness of bilateral and multilateral development assistance for health: a mixed- methods review of trends and strategic shifts (1990–2022). BMJ Global Health 2025;10:e017818. doi:10.1136/bmjgh-2024-017818. 12 January 2025. https://gh.bmj.com/content/10/1/e017818

10. Jialu Song, Ziqi Zhu, Qi Li, Ying Chen, Zhebin Wang, Shuduo Zhou, Ming Xu*,Zhi‑Jie Zheng. Comparative content analysis of national health policies, strategies and plans before and after COVID-19 among OECD and BRICS countries. Global Health Research and Policy (2025) 10:6, 21 Feb 2025. https://doi.org/10.1186/s41256-024-00400-y

Recent books and reports

1.Chief compiler, Introduction to public health security, Tsinghua University Press, 2024.

2. Marco Schäferhoff, Gavin Yamey, Osondu Ogbuoji, Ayodamope Fawole, Armand Zimmerman, Ipchita Bharali, Shingai Machingaidze, Ernesto J. Ortiz, Mosa Moshabela, Ming Xu*. Reforming the research and development ecosystem for neglected diseases, emerging infectious diseases, and maternal health.https://centerforpolicyimpact.org/wp-content/uploads/sites/18/2024/05/reforming-research-and-development-ecosystem-final.pdf